Join
Live feed
·
NEWSReleasevia Quantisnow
VBI Vaccines Inc. New logo

VBI Vaccines Reports New Tumor Response Data From Ongoing Randomized Controlled Phase 2b Study Of VBI-1901 For Patients With Recurrent Glioblastoma

ByQuantisnow·Wall Street's wire, on your screen.
VBIV· VBI Vaccines Inc. New
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track VBIV (VBI Vaccines Inc. New) and more on Quantisnow.